| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.3M | -1.1% | +1.8% |
| Cost of Revenue | $1.2M | -8.9% | -1.3% |
| R&D Expense | $730K | +2.9% | -0.7% |
| SG&A Expense | $2.2M | +14.8% | +29.9% |
| Operating Income | -$2.0M | -12.4% | -25.9% |
| Interest Expense | $70K | +1546.6% | -46.9% |
| Pre-tax Income | -$794K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $169K | -56.0% | -72.4% |
| Accounts Receivable | $94K | -0.2% | -8.1% |
| Current Assets | $1.1M | -32.6% | -56.7% |
| Total Assets | $3.1M | -20.2% | -49.6% |
| Current Liabilities | $29.7M | +0.7% | -21.1% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$534K | -695.0% | — |
| Capital Expenditures | $712 | -0.8% | — |
| Investing Cash Flow | -$360 | +66.1% | — |
| Financing Cash Flow | $368K | +144.6% | — |
| Free Cash Flow | -$535K | -700.6% | — |
| +81.1% |
| +76.3% |
| Net Income | -$794K | +81.1% | +76.3% |
| EPS (Basic) | -$0.07 | +86.0% | +98.4% |
| EPS (Diluted) | -$0.07 | +86.0% | +98.4% |
| $2.4M |
| — |
| -34.8% |
| Total Liabilities | $30.8M | +0.4% | -20.8% |
| Stockholders' Equity | -$27.7M | -3.4% | +15.4% |